PCSK9-Inhibiton as new Principle in Reducing the Lipid-Levels

Drexel, H; Malin, C; Saly, CH

Drexel, H (reprint author), VIVIT Inst, Carinagasse 47, A-6800 Feldkirch, Austria.

JOURNAL FUR KARDIOLOGIE, 2017; 24 (5-6): 102

Abstract

PCSK9 is an enzyme that promotes the catabolism of LDL receptors. Due to a reduced number of LDL receptors, cellular LDL uptake is reduced and LDL cho......

Full Text Link